TELA News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

TE

Mkt Cap

$44.2M

Volume

115.59K

Next Earnings

November 12th

Loading chart

TE

TELATELA Bio, Inc. Common Stock

TELA

Pay with—

Available Balance0.00

TE

Mkt Cap

$44.0M

Volume

115.59K

Next Earnings

November 12th

Chart Financials Earnings News About Insider Filings

TELA Bio Announces 510(k) Clearance for Liora™ Monofilament Scaffold for Soft Tissue ReinforcementTELA Bio announced FDA 510(k) clearance for its Liora Monofilament Scaffold, a fully resorbable surgical mesh device for soft tissue reinforcement. Liora is the first fully resorbable synthetic product in the company's portfolio to be designed and produced in-house at its ISO 8 certified cleanroom in Malvern, PA, expanding TELA Bio's soft tissue reconstruction market footprint.GlobeNewswire Inc. · Oct 5, 2026

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)TELA Bio, Inc. announced that its Compensation Committee approved inducement grants of restricted stock units covering 8,550 shares to three newly-hired employees with a grant date of February 18, 2026. The RSUs will vest in equal annual installments over four years, subject to continued service.GlobeNewswire Inc. · Feb 20, 2026

Hernia Repair Devices Market is Set to Attain Valuation of US$ 6.57 Billion by 2033 | Astute AnalyticaThe global hernia repair devices market is projected to reach US$ 6.57 billion by 2033, driven by rising procedural volumes, technological advancements, and increasing adoption of minimally invasive techniques. Key trends include the shift towards mesh implants, competition between open and laparoscopic repair, and the growing use of robotic platforms and biologic/biosynthetic materials.GlobeNewswire Inc. · Jun 25, 2025

TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional SharesTELA Bio, a medical technology company, announced the closing of its public offering of common stock and pre-funded warrants, raising $46 million. The company plans to use the proceeds for general corporate purposes.Benzinga · Oct 24, 2024

TELA Bio Appoints Jeffrey Blizard to its Board of DirectorsMALVERN, Pa., June 04, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (Nasdaq: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that it has appointed Jeffrey Blizard, the Global Head of Surgical Sales for Abiomed, a medical device technology company that operates as a stand-alone business within Johnson & Johnson's MedTech Segment, to its Board of Directors, effective June 4, 2024.GlobeNewswire Inc. · Jun 4, 2024

TELA Bio Appoints Greg Firestone as Chief Commercial OfficerMALVERN, Pa., May 20, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the appointment of Greg Firestone as the Company’s new Chief Commercial Officer. In this role, Mr. Firestone will oversee the Company’s commercial operations, including key product launches, sales team training, market development, as well as strategic initiatives to optimize market access and reimbursement strategy across the Company’s product lines.GlobeNewswire Inc. · May 20, 2024

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)MALVERN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 20,250 shares of its common stock to eleven newly-hired employees, with a grant date of May 6, 2024 (the "Grant Date"). The restricted stock units were granted pursuant to the Nasdaq Rule 5635(c)(4) inducement grant exception as a component of each individual's employment compensation and were granted as an inducement material to his or her acceptance of employment with TELA Bio.GlobeNewswire Inc. · May 10, 2024

Vertex Pharmaceuticals (VRTX) Q1 Earnings and Revenues Top EstimatesVertex (VRTX) delivered earnings and revenue surprises of 16.10% and 5.15%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?Zacks Investment Research · May 6, 2024

The Joint Corp. (JYNT) Beats Q1 Earnings and Revenue EstimatesThe Joint (JYNT) delivered earnings and revenue surprises of 300% and 1.91%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?Zacks Investment Research · May 2, 2024

TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia ProceduresTargets the more than 665,000 inguinal hernia procedures performed annually in the United States (U.S.) Targets the more than 665,000 inguinal hernia procedures performed annually in the United States (U.S.)GlobeNewswire Inc. · Apr 15, 2024

to start trading

TE

TELATELA Bio, Inc. Common Stock

TELA

Pay with—

Available Balance0.00

Your PositionYou don't own any TELA yet.

Related Tickers

Earnings